Quest Diagnostics Introduces Dako's PD-L1 Companion Diagnostic for KEYTRUDA®, Merck's Anti-PD-1 Therapy for Metastatic Non-Small Cell Lung Cancer
October 02, 2015 at 15:40 PM EDT
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it will provide ...